Patient Advocacy Committee

The BioNJ Patient Advocacy Committee strives to raise public awareness, educate and support the life sciences community regarding Patient Advocacy and its increasingly vital role in partnership with industry in the advancement of human health. Committee members develop programming for the annual Patient Advocacy Summit designed for anyone in New Jersey who advocates on behalf of Patients.

Committee Members

American Cancer Society Action Network – Samantha DeAlmeida, MA, MS, Government Relations Director, NJ
Amicus Therapeutics, Inc. – Jayne Gershkowitz, Chief Patient Advocate
Bristol-Myers Squibb Company – Ethan Hasbrouck, MPA, State Government Affairs
CancerCare – Michael Parisi, President of the Board
Celgene Corporation – Dmitri Siegel, MBA, Director, State Government Relations
Family Resource Network/Epilepsy Foundation of NJ – Liza Gundell, Chief Executive Officer
Immunomedics, Inc. – Lauren Wood, MBA, Head of Patient Experience & Corporate Communication
Multiple System Atrophy – Kim Roemer, MBA, EdD, Founder & Board Chair
Novartis Pharmaceutical – Candie Phipps, Director State Government & Business Affairs
Novartis Pharmaceutical – Vikki Walton, MBA, Director, State Public Policy & External Affairs
Pfizer, Inc. – Jennifer Deperry, MA, Alliance Development Manager
Pfizer, Inc. – Wendy Lazarus, Director, U.S. Government Relations
PTC Therapeutics, Inc. – Karen Galambos, Executive Director, Global Patient Advocacy
RASopathies Network USA – Lisa Schill, Vice President
Sanofi – Patricia Roselle, Patient Network Manager